Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Latest Post
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
BEAM-101 Receives RMAT for the Treatment of Sickle Cell Disease
Health
  • August 14, 2025
By AdminPrabadin - 19 hours ago
0

The designation is supported by promising results from the ongoing phase 1/2 BEACON clinical trial.

Previous article

Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling

Next article

Acetaminophen

AdminPrabadin
administrator

Related Articles

Health

After the Approval: Assessing RSV Vaccine Safety in…

  • August 14, 2025
Health

Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in…

  • August 14, 2025
Health

Pharmacists’ Knowledge Gaps on Kratom: Building Competence for…

  • August 14, 2025
© Copyright Barta 2018. Designed and Developed by Komarca Soft